High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

Completed · Phase 2

Conditions studied: Hematopoietic Cell Transplantation Recipient, Malignant Neoplasm, Influenza

In brief

This phase II randomized trial studies how well high dose flu vaccine works in treating children who have undergone done stem cell transplant. Higher dose flu vaccine may build a better immune response and may provide better protection against the flu than the standard vaccine.

Key facts

Study ID

NCT02860039

Run by

Vanderbilt-Ingram Cancer Center

People needed

170

Starts

2016-09-01

Expected to finish

2024-09-01

Last updated by the study team

2024-10-22

Who can join

Age: 3 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

Where it is running

• UCSF Children's Hospital — San Francisco, California, United States
• Children's Mercy Hospital — Kansas City, Missouri, United States
• Cincinnati Children's Hospital — Cincinnati, Ohio, United States
• Nationwide Children's Hospital — Columbus, Ohio, United States
• Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States
• St. Jude Children's Research Hospital — Memphis, Tennessee, United States
• Vanderbilt-Ingram Cancer Center — Nashville, Tennessee, United States
• Texas Children's Hospital — Houston, Texas, United States
• Seattle Children's Hospital Research Institute — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.